---
pmid: '16546175'
title: Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells
  by the alpha-glucosidase inhibitor miglustat.
authors:
- Norez C
- Noel S
- Wilke M
- Bijvelds M
- Jorna H
- Melin P
- DeJonge H
- Becq F
journal: FEBS Lett
year: '2006'
full_text_available: false
doi: 10.1016/j.febslet.2006.03.010
---

# Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat.
**Authors:** Norez C, Noel S, Wilke M, Bijvelds M, Jorna H, Melin P, DeJonge H, Becq F
**Journal:** FEBS Lett (2006)
**DOI:** [10.1016/j.febslet.2006.03.010](https://doi.org/10.1016/j.febslet.2006.03.010)

## Abstract

1. FEBS Lett. 2006 Apr 3;580(8):2081-6. doi: 10.1016/j.febslet.2006.03.010. Epub 
2006 Mar 10.

Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells 
by the alpha-glucosidase inhibitor miglustat.

Norez C(1), Noel S, Wilke M, Bijvelds M, Jorna H, Melin P, DeJonge H, Becq F.

Author information:
(1)Institut de Physiologie et Biologie Cellulaires, CNRS UMR 6187, Universit√© de 
Poitiers, 40 avenue du recteur Pineau, Poitiers 86022, France. 
cnorez@ext.univ-poitiers.fr

In the disease cystic fibrosis (CF), the most common mutation delF508 results in 
endoplasmic reticulum retention of misfolded CF gene proteins (CFTR). We show 
that the alpha-1,2-glucosidase inhibitor miglustat (N-butyldeoxynojirimycin, 
NB-DNJ) prevents delF508-CFTR/calnexin interaction and restores cAMP-activated 
chloride current in epithelial CF cells. Moreover, miglustat rescues a mature 
and functional delF508-CFTR in the intestinal crypts of ileal mucosa from 
delF508 mice. Since miglustat is an orally active orphan drug (Zavesca) 
prescribed for the treatment of Gaucher disease, our findings provide the basis 
for future clinical evaluation of miglustat in CF patients.

DOI: 10.1016/j.febslet.2006.03.010
PMID: 16546175 [Indexed for MEDLINE]
